Skip to main content
Top
Published in: Annals of Surgical Oncology 7/2014

01-07-2014 | Bone and Soft Tissue Sarcomas

Sporadic Abdominal Wall Desmoid: Is it Time to Change Our First-Line Approach?

Author: Sylvie Bonvalot, MD, PhD

Published in: Annals of Surgical Oncology | Issue 7/2014

Login to get access

Excerpt

The team of the Royal Marsden of London reported a series of 50 patients who underwent the resection of a primary sporadic abdominal wall desmoid tumor (DT).1 This field is changing rapidly as new data accumulates, and a personalized approach that takes into account the initial tumor size and/or the evolution after initial surveillance is becoming the preferred method.2
Literature
1.
go back to reference Wilkinson MJ, Chan KE, Hayes AJ, Strauss DC. Surgical outcomes following resection for sporadic abdominal wall fibromatosis. Ann Surg Oncol. 2014 (in press). Wilkinson MJ, Chan KE, Hayes AJ, Strauss DC. Surgical outcomes following resection for sporadic abdominal wall fibromatosis. Ann Surg Oncol. 2014 (in press).
2.
go back to reference Gronchi A, Colombo C, Le Péchoux C, et al. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm—a position paper from the Italian and the French Sarcoma Group. Ann Oncol. 2014;25(3):578–83.PubMedCrossRef Gronchi A, Colombo C, Le Péchoux C, et al. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm—a position paper from the Italian and the French Sarcoma Group. Ann Oncol. 2014;25(3):578–83.PubMedCrossRef
3.
go back to reference Bonvalot S, Ternès N, Fiore M, et al. Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought. Ann Surg Oncol. 2013;20(13):4096–102.PubMedCrossRef Bonvalot S, Ternès N, Fiore M, et al. Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought. Ann Surg Oncol. 2013;20(13):4096–102.PubMedCrossRef
4.
go back to reference Salas S, Dufresne A, Bui B, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol. 2011; 29(26):3553–58.PubMedCrossRef Salas S, Dufresne A, Bui B, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol. 2011; 29(26):3553–58.PubMedCrossRef
5.
go back to reference Fiore M, Coppola S, Cannell AJ, et al. Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg 2013 (in press). Fiore M, Coppola S, Cannell AJ, et al. Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg 2013 (in press).
6.
go back to reference Colombo C, Miceli R, Lazar AJ, et al. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study. Cancer. 2013;119(20):3696–702.PubMed Colombo C, Miceli R, Lazar AJ, et al. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study. Cancer. 2013;119(20):3696–702.PubMed
Metadata
Title
Sporadic Abdominal Wall Desmoid: Is it Time to Change Our First-Line Approach?
Author
Sylvie Bonvalot, MD, PhD
Publication date
01-07-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 7/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3699-1

Other articles of this Issue 7/2014

Annals of Surgical Oncology 7/2014 Go to the issue